Skip to main content
Journal cover image

Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy.

Publication ,  Journal Article
Lian, X; Seiger, KW; Parsons, EM; Gao, C; Sun, W; Gladkov, GT; Roseto, IC; Einkauf, KB; Osborn, MR; Chevalier, JM; Jiang, C; Blackmer, J ...
Published in: Cell host & microbe
January 2023

HIV-1 establishes a life-long reservoir of virally infected cells which cannot be eliminated by antiretroviral therapy (ART). Here, we demonstrate a markedly altered viral reservoir profile of long-term ART-treated individuals, characterized by large clones of intact proviruses preferentially integrated in heterochromatin locations, most prominently in centromeric satellite/micro-satellite DNA. Longitudinal evaluations suggested that this specific reservoir configuration results from selection processes that promote the persistence of intact proviruses in repressive chromatin positions, while proviruses in permissive chromosomal locations are more likely to be eliminated. A bias toward chromosomal integration sites in heterochromatin locations was also observed for intact proviruses in study participants who maintained viral control after discontinuation of antiretroviral therapy. Together, these results raise the possibility that antiviral selection mechanisms during long-term ART may induce an HIV-1 reservoir structure with features of deep latency and, possibly, more limited abilities to drive rebound viremia upon treatment interruptions.

Duke Scholars

Published In

Cell host & microbe

DOI

EISSN

1934-6069

ISSN

1931-3128

Publication Date

January 2023

Volume

31

Issue

1

Start / End Page

83 / 96.e5

Related Subject Headings

  • Virus Latency
  • Viral Load
  • Proviruses
  • Immunology
  • Humans
  • Heterochromatin
  • HIV-1
  • HIV Infections
  • CD4-Positive T-Lymphocytes
  • Antiviral Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lian, X., Seiger, K. W., Parsons, E. M., Gao, C., Sun, W., Gladkov, G. T., … Lichterfeld, M. (2023). Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy. Cell Host & Microbe, 31(1), 83-96.e5. https://doi.org/10.1016/j.chom.2022.12.002
Lian, Xiaodong, Kyra W. Seiger, Elizabeth M. Parsons, Ce Gao, Weiwei Sun, Gregory T. Gladkov, Isabelle C. Roseto, et al. “Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy.Cell Host & Microbe 31, no. 1 (January 2023): 83-96.e5. https://doi.org/10.1016/j.chom.2022.12.002.
Lian X, Seiger KW, Parsons EM, Gao C, Sun W, Gladkov GT, et al. Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy. Cell host & microbe. 2023 Jan;31(1):83-96.e5.
Lian, Xiaodong, et al. “Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy.Cell Host & Microbe, vol. 31, no. 1, Jan. 2023, pp. 83-96.e5. Epmc, doi:10.1016/j.chom.2022.12.002.
Lian X, Seiger KW, Parsons EM, Gao C, Sun W, Gladkov GT, Roseto IC, Einkauf KB, Osborn MR, Chevalier JM, Jiang C, Blackmer J, Carrington M, Rosenberg ES, Lederman MM, McMahon DK, Bosch RJ, Jacobson JM, Gandhi RT, Peluso MJ, Chun T-W, Deeks SG, Yu XG, Lichterfeld M. Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy. Cell host & microbe. 2023 Jan;31(1):83-96.e5.
Journal cover image

Published In

Cell host & microbe

DOI

EISSN

1934-6069

ISSN

1931-3128

Publication Date

January 2023

Volume

31

Issue

1

Start / End Page

83 / 96.e5

Related Subject Headings

  • Virus Latency
  • Viral Load
  • Proviruses
  • Immunology
  • Humans
  • Heterochromatin
  • HIV-1
  • HIV Infections
  • CD4-Positive T-Lymphocytes
  • Antiviral Agents